AMT to Release Full Year 2007 Results on Februar... ( AMSTERDAM February 12 /- Amsterda...)

AMT to Release Full Year 2007 Results on February 20, 2008

Date:2/12/2008

AMSTERDAM, February 12 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it will release its financial results for the full year 2007 on Wednesday, February 20, 2008 at 7:30 am Central European Time (CET). To discuss these results, the Company will conduct a conference call at 10 am CET. Netherlands Dial In: 0800-949-4517 (toll free); US Dial In: +1-866-291-4166 (toll free); UK Dial In: +44-207-107-0611. To listen to the conference call live via the internet, visit the investor relations portion of the AMT website at http://www.amtbiopharma.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV GMP production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of (rare) diseases that are caused by one faulty gene. AMT currently has a product pipeline with six products at different stages of development.

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/9/2009)...wire/ -- "Micro cap and small cap equities across ...ponsorship and exposure as a ,buying window, opens...driven stocks like gold, silver and other metals,"... Inc, Manhattan based investor relations firm with...arket in the US and Canada, and with expansion pla...

(Date:11/9/2009)...swire-FirstCall/ -- BioMed Realty Trust, Inc. (NYS...eived commitments from lenders to increase the bor... $65 million to an aggregate of $665 million, with...he weighted-average effective interest rate of the...r 30, 2009. The maturity date remains August 1, 20...

(Date:11/9/2009)...Newswire-Asia/ -- The pharma and biotech sectors a...panies are facing significant,pressure to change w..., calls for,lower prices and a greater regulatory ...al crisis have made the work of creating new drugs...e being forced to globalize their R&D,operatio...

(Date:11/9/2009)...ewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Am...enthal, Professor of Immunology and Microbiology o...ne and Pharmacy, reported on work conducted in col... and CEL-SCI on CEL-SCI,s LEAPS vaccine technology...e: "All Things Considered" Conference in Crystal C...

Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2 BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2 BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3 Pharma and Biotech Leaders to Converge in Shanghai 2 CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2 CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3

[0] Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge [0] BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million [0] Pharma and Biotech Leaders to Converge in Shanghai [0] CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response

... , , , for amplification of GC-rich t... No. 2 140 306 50 PCR reactions , , , ..., Unique enzyme blend of Taq DNA Polymerase a...me with a proofreading (3,5, exonuclease) , ...includes: , , An optimized GC-R...

... , , , Highly purified deoxynucleotide...vity in all PCR and RT-PCR applications, , ...e with PCR Grade Nucleotides! , Produce sen...oped PCR grade , deoxy-nucleotides from RAS..., RT-PCR assays, even when analyzing low cop...

... , , , for one-step RT-PCR amplificat...016 338 50 reactions , Cat. No. 2 016 346 2...Description , , , The system contains ...rase and Taq DNA Polymerase. , , No... Science is the recombinant , form of the D...

Other Biology Technology:GC-RICH PCR System 2 PCR Grade Deoxynucleotides 2 PCR Grade Deoxynucleotides 3 PCR Grade Deoxynucleotides 4 PCR Grade Deoxynucleotides 5 C. therm. Polymerase One-Step RT-PCR System 2 C. therm. Polymerase One-Step RT-PCR System 3

GC-RICH PCR System PCR Grade Deoxynucleotides C. therm. Polymerase One-Step RT-PCR System

(Date:11/9/2009)... children with cancer, the hopeful news is that pe...decades. Among the bad newstreatments that enable ...osed with cancer who have reached puberty currentl... before undergoing cancer treatment, they may have...Younger boys, however, do not produce sperm, altho...

(Date:11/9/2009)...Ala. The U.S. Department of Energy (DOE) has anno...Alabama at Birmingham (UAB) School of Engineering ...gas emissions through the capture and permanent sa...O2). The project is in collaboration with Southern... Funded by the DOE through the 2009 American Recov...

(Date:11/9/2009)...ournal Naturwissenschaften is publishing a speci...dern Biology" to commemorate Darwin,s On the Origi...November 1859. Guest editor and author of the lead...nt physiology and evolutionary biology at the Univ...special issue are available free of charge until 3...

[0] For young boys with cancer, testicular tissue banking may be option to preserve fertility [0] UAB, partners seek safe carbon dioxide storage for 'greener' power generation [0] Charles Darwin and modern biology

...rus,s hemagglutinin receptor binding site—a molecu...—stopped viral transmission in ferrets, according ...inai School of Medicine and at the Centers for Dis...d in the February 1 issue of Science, could have s...ists develop ways to break the disease cycle and p...

... University of Georgia scientists suggests that cu... do little ?if anything ?to reduce rates of antibi... threaten human health. , Dr. Margie Lee, profess...her colleagues have found that chickens raised on ...pristine laboratory conditions have high levels of...

...results in an enhanced long-term memory, researche...l Cell, published by Cell Press. These findings po... drug to treat memory loss, according to the resea...ally increases levels of a natural memory-blocking...f this gene showed improved performance in classic...

Other Biology News:Changes in amino acids in the 1918 influenza virus cut transmission 2 Changes in amino acids in the 1918 influenza virus cut transmission 3 Study finds antibiotic resistance in poultry even when antibiotics were not used 2 Study finds antibiotic resistance in poultry even when antibiotics were not used 3 Mutation improves memory, may lead to memory-enhancing pill 2 Mutation improves memory, may lead to memory-enhancing pill 3

Changes in amino acids in the 1918 influenza virus cut transmission Study finds antibiotic resistance in poultry even when antibiotics were not used Mutation improves memory, may lead to memory-enhancing pill

CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* from Molecular Probes (Invitrogen)

Canine IL-10 ELISpot Development Kit from R&D Systems

Equine TNF ALPHA from AbD Serotec

DETACHaBEAD CD19 from Dynal Biotech

Biology Products:

CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* from Molecular Probes (Invitrogen)Canine IL-10 ELISpot Development Kit from R&D Systems Equine TNF ALPHA from AbD Serotec DETACHaBEAD CD19 from Dynal Biotech

AMT to Release Full Year 2007 Results on Februar...( AMSTERDAM February 12 /- Amsterda...)